See CDR Update 130 for important news and information regarding the CADTH Common Drug Review.
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
Ottawa, ON (November 8, 2017) — For Canadians living with end-stage kidney disease, undergoing dialysis at home should be considered as an alternative to regular visits to a dialysis centre, according to new evidence and expert recommendations from CADTH.
“The evidence tells us that in-centre and home-based dialysis offer similar benefits in ter...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
On October 3, 2017, the Honourable Ginette Petitpas Taylor, Federal Minister of Health, announced a national external review of eight federally funded pan-Canadian health organizations (PCHOs), including CADTH. Dr. Danielle Martin and Dr. Pierre-Gerlier Forest have been appointed to co-lead the review.
The review will be a time-limited and forwa...